Pharmacokinetics (PK), pharmacodynamics (PD) and immunogenicity of moxetumomab pasudotox (Moxe), an immunotoxin targeting CD22, in adult patients (Pts) with relapsed or refractory hairy cell leukemia (HCL)

Pharmacokinetics (PK), pharmacodynamics (PD) and immunogenicity of moxetumomab pasudotox (Moxe), an immunotoxin targeting CD22, in adult patients (Pts) with relapsed or refractory hairy cell leukemia (HCL)

Abstract only

Saved in:
Bibliographic Details
Published in:Journal of clinical oncology Vol. 36; no. 15_suppl; p. 7061
Main Authors: Balic, Kemal, Standifer, Nathan, Santiago, Linda, Kuruvilla, Denison, Yao, Nai-Shun, Kreitman, Robert J., Pastan, Ira, Li, Xia, Liang, Meina, Vainshtein, Inna, Tseng, Chih-Ming, Faggioni, Raffaella, Roskos, Lorin
Format: Journal Article
Language:English
Published: 20-05-2018
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/JCO.2018.36.15_suppl.7061